Ōura key facts
as of Oct 2026- Developer of a wellness wearable string designed to track and improve sleep quality and performance.
- Ōura is valued at approximately $11.0B as of Oct 2026 (last reported valuation).
- It has raised $2.1B; the latest was Later Stage VC ($907.7M) in Oct 2025.
- Notable investors include Alumni Ventures, Fidelity Management & Research Company, Gaingels, Metaplanet Holdings, European Union — 53 tracked in total.
- Status: Privately Held (backing).
Ōura's last reported valuation, Oct 2025. Nothing priced has surfaced since.
- ·The complete investor list: 53 names
- ·Everyone on the team, board and advisors included
- ·Watch Ōura: the Monday email on marks, rounds and moves
Ōura funding rounds
No funding rounds for Ōura are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Ōura leadership
- Ricky BloomfieldChief Medical Officer
- Avonte Campinha-BacoteChief Legal Officer & Secretary
- Adi ShammoutChief Information Officer
- Dorothy KilroyExecutive
Who backs Ōura
53+Ōura valuation
Ōura's last reported valuation was $11 billion in Oct 2025. No priced round, secondary trade or fund mark has surfaced since.
Ōura investors
53 investors are on record for Ōura, including Alumni Ventures, Fidelity Management & Research Company, Gaingels and Metaplanet Holdings. By type, the record holds 13 venture capital firms, 2 family offices and 1 asset manager.
Who runs Ōura
16 people are listed on the Ōura team: 15 executives and 1 board member, including Thomas Hale (Chief Executive Officer) and Michael Chapp (Chief Operating Officer). 15 of them have a verified direct contact on file.
Comparable companies
Comparable therapeutic devices names by valuation on PrivateMarketView: SetPoint Medical ($480 million), Saluda Medical ($435 million) and LightForce ($400 million).
About Ōura
Developer of a wellness wearable string designed to track and improve sleep quality and performance. The company's product tracks sleep quality, stages, electrocardiogram level, resting heart rate, and variability, as well as body temperature during the night through an intelligent data-driven plan by detecting changes in blood pulse volume, enabling users to improve their sleep and overall health and align with their natural circadian rhythm.
- Industry
- Therapeutic Devices
- Sector
- Healthcare
- HQ
- Oulu, Finland
- Founded
- 2013
- Employees
- 900
- Website
- ouraring.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.